Isabel Ben‐Batalla

1.6k total citations
24 papers, 718 citations indexed

About

Isabel Ben‐Batalla is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Isabel Ben‐Batalla has authored 24 papers receiving a total of 718 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 11 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Isabel Ben‐Batalla's work include Phagocytosis and Immune Regulation (11 papers), CAR-T cell therapy research (4 papers) and Angiogenesis and VEGF in Cancer (4 papers). Isabel Ben‐Batalla is often cited by papers focused on Phagocytosis and Immune Regulation (11 papers), CAR-T cell therapy research (4 papers) and Angiogenesis and VEGF in Cancer (4 papers). Isabel Ben‐Batalla collaborates with scholars based in Germany, Norway and United States. Isabel Ben‐Batalla's co-authors include Sonja Loges, Román Pérez-Fernández, Melanie Janning, Rosalı́a Gallego, Gunhild von Amsberg, José Luis Relova, Mark Wroblewski, Carsten Bokemeyer, Klaus Pantel and Thomas Schmidt and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Isabel Ben‐Batalla

24 papers receiving 714 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Isabel Ben‐Batalla Germany 13 282 267 167 84 82 24 718
Paola Portararo Italy 15 366 1.3× 357 1.3× 243 1.5× 41 0.5× 78 1.0× 23 947
Shuhong Wang China 16 367 1.3× 171 0.6× 211 1.3× 46 0.5× 167 2.0× 66 899
Juan José Múñoz Spain 19 479 1.7× 232 0.9× 174 1.0× 41 0.5× 60 0.7× 47 1.1k
Jennifer J. Tsai United States 11 245 0.9× 447 1.7× 211 1.3× 54 0.6× 61 0.7× 22 878
Charles Link United States 18 296 1.0× 277 1.0× 391 2.3× 49 0.6× 71 0.9× 40 983
Zhao Cheng China 18 389 1.4× 129 0.5× 93 0.6× 29 0.3× 121 1.5× 65 781
Chun Cao Switzerland 10 582 2.1× 117 0.4× 175 1.0× 44 0.5× 42 0.5× 13 750
Solomon A. Graf United States 13 313 1.1× 66 0.2× 165 1.0× 138 1.6× 30 0.4× 45 695
Madhu P. Menon United States 15 215 0.8× 112 0.4× 215 1.3× 196 2.3× 46 0.6× 39 781
Ute Ungethüm Germany 15 503 1.8× 143 0.5× 141 0.8× 28 0.3× 226 2.8× 25 874

Countries citing papers authored by Isabel Ben‐Batalla

Since Specialization
Citations

This map shows the geographic impact of Isabel Ben‐Batalla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabel Ben‐Batalla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabel Ben‐Batalla more than expected).

Fields of papers citing papers by Isabel Ben‐Batalla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabel Ben‐Batalla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabel Ben‐Batalla. The network helps show where Isabel Ben‐Batalla may publish in the future.

Co-authorship network of co-authors of Isabel Ben‐Batalla

This figure shows the co-authorship network connecting the top 25 collaborators of Isabel Ben‐Batalla. A scholar is included among the top collaborators of Isabel Ben‐Batalla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabel Ben‐Batalla. Isabel Ben‐Batalla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schmidt, Claudia, et al.. (2024). Prolonged inhibition of intratumoral mast cells enhances efficacy of low‐dose antiangiogenic therapy. International Journal of Cancer. 156(1). 186–200. 1 indexed citations
2.
Ben‐Batalla, Isabel, et al.. (2023). The Role of TAM Receptors in Bone. International Journal of Molecular Sciences. 25(1). 233–233. 2 indexed citations
3.
Weber, Florian, Mark Wroblewski, Isabel Ben‐Batalla, et al.. (2022). The HDL particle composition determines its antitumor activity in pancreatic cancer. Life Science Alliance. 5(9). e202101317–e202101317. 19 indexed citations
4.
Waizenegger, Jonas, Friederike Hoffmann, Philippe Schafhausen, et al.. (2021). AXL Inhibition Represents a Novel Therapeutic Approach in BCR-ABL Negative Myeloproliferative Neoplasms. HemaSphere. 5(9). e630–e630. 5 indexed citations
5.
Ben‐Batalla, Isabel, et al.. (2020). Influence of Androgens on Immunity to Self and Foreign: Effects on Immunity and Cancer. Frontiers in Immunology. 11. 1184–1184. 88 indexed citations
6.
Wroblewski, Mark, Isabel Ben‐Batalla, Ines Miranda Santos, et al.. (2018). Blockade of Myeloid-Derived Suppressor Cell Expansion with All- Trans Retinoic Acid Increases the Efficacy of Antiangiogenic Therapy. Cancer Research. 78(12). 3220–3232. 97 indexed citations
7.
Ben‐Batalla, Isabel, et al.. (2018). Sexual dimorphism in solid and hematological malignancies. Seminars in Immunopathology. 41(2). 251–263. 24 indexed citations
8.
9.
Ben‐Batalla, Isabel, Hanna Taipaleenmäki, Kristoffer Riecken, et al.. (2018). Blockade of Mer By the Small Molecule Inhibitor R992 Inhibits Multiple Myeloma and Its Associated Bone Disease By Restoring the Perturbed Bone Homeostasis. Blood. 132(Supplement 1). 1922–1922. 1 indexed citations
10.
Wroblewski, Mark, Isabel Ben‐Batalla, Karen Legler, et al.. (2017). Mast cells decrease efficacy of anti-angiogenic therapy by secreting matrix-degrading granzyme B. Nature Communications. 8(1). 269–269. 66 indexed citations
11.
Loges, Sonja, Isabel Ben‐Batalla, Michael Heuser, et al.. (2017). Axl blockade in vitro and in patients with high-risk MDS by the small molecule inhibitor BGB324.. Journal of Clinical Oncology. 35(15_suppl). 7059–7059. 2 indexed citations
12.
Ben‐Batalla, Isabel, Mark Wroblewski, Jonas Waizenegger, et al.. (2015). Cyclooxygenase-2 blockade can improve efficacy of VEGF-targeting drugs. Oncotarget. 6(8). 6341–6358. 30 indexed citations
13.
Krause, Sarah, Christian Pfeiffer, Ameera Alsadeq, et al.. (2014). Mer tyrosine kinase promotes the survival of t(1;19)-positive acute lymphoblastic leukemia (ALL) in the central nervous system (CNS). Blood. 125(5). 820–830. 38 indexed citations
14.
Nagarajan, Sankari, Tareq Hossan, Malik Alawi, et al.. (2014). Bromodomain Protein BRD4 Is Required for Estrogen Receptor-Dependent Enhancer Activation and Gene Transcription. Cell Reports. 8(2). 460–469. 130 indexed citations
15.
Schultze, Alexander, Isabel Ben‐Batalla, Sabine Riethdorf, et al.. (2012). VEGFR-1 expression levels predict occurrence of disseminated tumor cells in the bone marrow of patients with esophageal carcinoma. Clinical & Experimental Metastasis. 29(8). 879–887. 5 indexed citations
16.
Schmidt, Thomas, Isabel Ben‐Batalla, Alexander Schultze, & Sonja Loges. (2011). Macrophage–tumor crosstalk: role of TAMR tyrosine kinase receptors and of their ligands. Cellular and Molecular Life Sciences. 69(9). 1391–1414. 34 indexed citations
17.
Ben‐Batalla, Isabel, Samuel Seoane, Tomás García‐Caballero, et al.. (2010). Deregulation of the Pit-1 transcription factor in human breast cancer cells promotes tumor growth and metastasis. Journal of Clinical Investigation. 120(12). 4289–4302. 41 indexed citations
18.
Ben‐Batalla, Isabel, Samuel Seoane, Manuel Macı́a, et al.. (2009). The Pit-1/Pou1f1 transcription factor regulates and correlates with prolactin expression in human breast cell lines and tumors. Endocrine Related Cancer. 17(1). 73–85. 15 indexed citations
19.
20.
Seoane, Samuel, et al.. (2007). Cellular Expression Levels of the Vitamin D Receptor Are Critical to Its Transcriptional Regulation by the Pituitary Transcription Factor Pit-1. Molecular Endocrinology. 21(7). 1513–1525. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paola Portararo Breakdown of academic impact, for papers by Shuhong Wang Breakdown of academic impact, for papers by Juan José Múñoz Breakdown of academic impact, for papers by Jennifer J. Tsai Breakdown of academic impact, for papers by Charles Link Breakdown of academic impact, for papers by Zhao Cheng Breakdown of academic impact, for papers by Chun Cao Breakdown of academic impact, for papers by Solomon A. Graf Breakdown of academic impact, for papers by Madhu P. Menon Breakdown of academic impact, for papers by Ute Ungethüm
Rankless by CCL
2026